Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Decred (DCR) vs Injective (INJ) Price & Performance

DecredTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Decred vs Injective — how do they compare? Decred trades at Rp236,768 (market cap Rp4,22T, Rp368,36M 24h volume), while Injective trades at Rp85,566 (market cap Rp8,48T, Rp1,32T 24h volume). The key difference: Injective is far larger — about 2× Decred's market cap, and Decred's supply is capped (17,5M / 21M DCR (84%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Decred for 11 Days and Injective for 36 Days on average.

DCRINJ
Market Cap
Rp4,22TRp8,48T
Volume (24h)
Rp368,36MRp1,32T
Circulating Supply
17,5M / 21M DCR (84%)100M INJ
Typical Hold Time
11 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Decred

Decred (DCR) is trading at Rp245,464 with a market cap of Rp4.25 trillion, showing a bearish technical signal from moving averages while oscillators remain neutral. The asset faces resistance near Rp200,528–Rp204,034, with support levels at Rp193,516–Rp197,022. No major protocol updates or ecosystem news are noted recently, and on-chain activity appears subdued with an average hold time of 11 days.

Overall outlook is cautious due to bearish technicals and lack of fundamental catalysts. Key opportunities include potential rebounds from support zones, but risks involve low liquidity, high volatility, and regulatory uncertainty in the crypto space. Investors should monitor network activity for signs of renewed adoption.

Injective

Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.

Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DCR
100% Buy0% Sell
Avg holding period · 11 Days
INJ
4% Buy96% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Decred

Decred, launched in 2016, is a cryptocurrency focused on security, user control, and adaptability. It uses a hybrid system combining Proof-of-Work (PoW) and Proof-of-Stake (PoS), allowing both miners and coin holders to participate in decision-making. This approach helps secure the network and ensures Decred can quickly adapt to changes.

Read more on DCR

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ